)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
COMPASS Pathways
COMPASS Pathways (CMPS) investor relations material
COMPASS Pathways TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.TD Cowen 46th Annual Health Care Conference summary3 Mar, 2026
Key clinical trial results
Phase III studies (005 and 006) showed statistically significant MADRS score improvements at all measured time points, with rapid onset and sustained effects up to 26 weeks after administration.
A second dose provided additional benefit, increasing both the depth and breadth of response, with remission rates rising to 40% in some groups.
Consistency in primary endpoints and durability of response was observed across multiple trials, including long-term follow-up.
The 10 mg dose showed inconsistent results and will not be the initial focus for regulatory filing, though it is being explored in PTSD trials.
Quality of life and patient-reported outcomes will be included in future data releases, with more comprehensive analyses expected in early Q3.
Clinical and commercial implications
A 25% reduction in MADRS is considered clinically meaningful, translating to significant improvements in patient quality of life.
Rapid identification of responders within 24 hours is highly differentiated from current TRD treatments, offering hope and potentially life-saving benefits.
Safety profile is favorable, with a low barrier to trying the treatment due to quick response and minimal safety concerns.
Existing infrastructure for similar treatments (e.g., SPRAVATO) can be leveraged for administration and monitoring, minimizing operational changes.
REMS requirements are expected to be similar to SPRAVATO, with licensed healthcare providers on site and standard monitoring protocols.
Regulatory and strategic updates
Ongoing, collaborative relationship with the FDA, with data submitted on a rolling basis and breakthrough designation accelerating timelines.
No shortcuts in development; robust trial designs and comprehensive safety data support regulatory filings.
The company is not prioritizing the Commissioner's voucher due to limited added value given the accelerated review process.
Real-world evidence post-approval will help refine patient profiles and further inform commercial strategy.
Conference presentations and additional data releases are planned for later in the year.
Revisit 10mg dose strategy for TRD
How does rapid response differentiate COMP360?
Clarify REMS site operational burden
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next COMPASS Pathways earnings date
Q4 202512 Mar, 2026
COMPASS Pathways
Next COMPASS Pathways earnings date
Q4 202512 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
COMPASS Pathways Plc is a mental health care company developing psychedelic-based therapies for the treatment of mental health disorders. The company focuses on clinical research and development of psilocybin-assisted therapies for conditions such as treatment-resistant depression. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage